Search Results - "Cerveró, D."

P17.4 Ischaemic versus neuropathic pain by Montoya, F.J., Pérez-Saldaña, M.T., Molina, J., Orenga, J., Cerveró, D., Serrano, A.L.

Get full text

Frontal absences and 'pseudo-absences' by Ortega-Albás, J J, Serrano, A L, López-Bernabé, R, Cerveró-Albert, D, Vera, J F

Get full text

Intraoperative complications of phacoemulsification in pseudoexfoliation: Metaanalysis by Vazquez-Ferreiro, Pedro, MD, Carrera-Hueso, Francisco J., PhD, Poquet Jornet, Jaime E., PhD, Fikri-Benbrahim, Narjis, PhD, Diaz-Rey, Marta, MD, Sanjuan-Cerveró, Rafael, MD

“…This review analyzed the effect of pseudoexfoliation (PXF) syndrome on the risk for surgical complications during phacoemulsification. Peer-reviewed literature…”
Get full text

Ausencias y ‘pseudoausencias’ frontales by Ortega Albás, Juan José, Serrano García, A.L., López Bernabé, Roberto, Cerveró Albert, Dolors, Vera Lorenzo, J.F.

Get full text

Dolutegravir plus rilpivirine: benefits beyond viral suppression by Jesús Troya, MD, PhD, Carlos Dueñas, MD, Idoia Irazola, MD, Ignacio de los Santos, MD, PhD, Sara de la Fuente, MD, PhD, Desiré Gil, MD, PhD, Cristina Hernández, MD, María José Galindo, MD, PhD, Julia Gómez, MD, Elisabeth Delgado, MD, Estela Moreno-García, MD, Guillermo Posada, MD, PhD, Teresa Aldámiz, MD, PhD, Jose Antonio Iribarren, MD, José Manuel Guerra, MD, PhD, Miguel Ángel Morán, MD, Carlos Galera, MD, PhD, Javier Fuente, MD, Ana Peláez, MD, PhD, Miguel Cervero, MD, PhD, María Garcinuño, MD, Marta Montero, MD, Francisco Ceballos, PhD, Luis Buzón, MD, PhD, on behalf of the DORIPEX Study Group∗∗

“…Switching dual therapy with dolutegravir (DTG) plus rilpivirine (RPV) was assessed in the SWORD-1 and SWORD-2 studies. Real-life data regarding the…”
Get full text